Comparative evaluation of efficacy and safety of ophthalmic viscosurgical devices in phacoemulsification [ ISRCTN 34957881 ]

Background: Various ophthalmic viscosurgical devices (OVD) are used to perform phacoemulsification and other intraocular surgeries. We performed a study to compare the efficacy and safety of three ophthalmic viscosurgical devices that are routinely used in phacoemulsification. Methods: Fifty-six patients of immature senile cataract with hard nucleus (grade 3 and 4) who underwent phacoemulsification were included. Depending upon the type of OVD, patients were randomly allocated into three groups; group 1 (n = 19), Viscoat® was used; group 2 (n = 19), Healon GV® was used; group 3 (n = 18), Healon 5® was used. Parameters evaluated were uncorrected and best corrected visual acuity, specular microscopy, intraocular pressure and pachymetry both preoperatively and postoperatively on day 1, 1 week, 1 month and 3 months and development of any complication both intraoperative and postoperative were also noted. Results: The mean increase in central corneal thickness was 15.17% (group 1); 17.26% (group 2) and 16.21% (group 3) on first postoperative day and was comparable in the three groups. The density of endothelial cells decreased postoperatively (day 1) by 12.54% (group 1), 13.76% (group 2) and 13.06% (group 3) and was comparable. The mean preoperative intraocular pressure in groups 1, 2 and 3 were 13.3 ± 2.0, 14.0 ± 2.2 and 13.2 ± 3.2 mmHg respectively, which changed to 16.0 ± 4.7, 12.2 ± 4.7 and 12.3 ± 4.8 respectively on first postoperative day and the change in intraocular pressure was significantly higher in group 1 (1 vs 2 & 1 vs 3; p = 0.02; oneway ANOVA). Conclusion: Viscoat®, Healon GV® and Healon 5® give comparable results in terms of efficacy and safety in performing phacoemulsification. Background Ophthalmic Viscosurgical Devices (OVDs) have played a key role in the success of phacoemulsification. An ideal OVD is one which is able to maintain the anterior Published: 15 July 2005 BMC Ophthalmology 2005, 5:17 doi:10.1186/1471-2415-5-17 Received: 23 December 2004 Accepted: 15 July 2005 This article is available from: http://www.biomedcentral.com/1471-2415/5/17 © 2005 Vajpayee et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

[1]  K. Miyata,et al.  Corneal endothelial cell protection during phacoemulsification: Low‐ versus high‐molecular‐weight sodium hyaluronate , 2002, Journal of cataract and refractive surgery.

[2]  J. Legeais,et al.  Nineteen Years of Penetrating Keratoplasty in the Hotel-Dieu Hospital in Paris , 2001, Cornea.

[3]  I. Wang,et al.  Changing Indications for Penetrating Keratoplasty in Taiwan from 1987 to 1999 , 2001, Cornea.

[4]  Huiyang The Clinical Study of Healon 5 in Phacoemulsification and IOL Implantation , 2001 .

[5]  K. Dobbins,et al.  Trends in the Indications for Penetrating Keratoplasty in the Midwestern United States , 2000, Cornea.

[6]  O. Schwenn,et al.  Healon5 versus Viscoat during cataract surgery: intraocular pressure, laser flare and corneal changes , 2000, Graefe's Archive for Clinical and Experimental Ophthalmology.

[7]  T. Dada,et al.  Phacoemulsification of white hypermature cataract. , 1999, Journal of cataract and refractive surgery.

[8]  P. Asbell,et al.  Changing Indications for Penetrating Keratoplasty: Histopathology of 1,250 Corneal Buttons , 1998, Cornea.

[9]  G. Ravalico,et al.  Corneal endothelial protection by different viscoelastics during phacoemulsification , 1997, Journal of cataract and refractive surgery.

[10]  H. Hayashi,et al.  Risk factors for corneal endothelial injury during phacoemulsification , 1996, Journal of cataract and refractive surgery.

[11]  J. Grossiord,et al.  [Dynamic viscosity and corneal endothelial protection with Healonid, Healon GV, Provisc and Viscoat during phacoemulsification]. , 1996, Journal francais d'ophtalmologie.

[12]  W. Haining,et al.  A Double Blind Randomized Multicentre Clinical Trial of ‘Healon G.V.’ Compared with ‘Healon’ in ECCE with IOL Implantation , 1991 .

[13]  S. Arshnoff The physical properties of ophthalmic viscoelastics in cataract surgery , 1991 .

[14]  D. Glasser,et al.  Protective effects of viscous solutions in phacoemulsification and traumatic lens implantation. , 1989, Archives of ophthalmology.

[15]  E. Balazs,et al.  The use of sodium hyaluronate (Healon) in human anterior segment surgery. , 1980, Ophthalmology.